Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 132

Results For "RSE"

1703 News Found

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults


Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
News | March 29, 2022

Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic


USFDA approves EUA for second booster dose of Moderna
News | March 29, 2022

USFDA approves EUA for second booster dose of Moderna

50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age


EU and European Disability Forum laud efforts of Sightsavers in India
Public Health | March 28, 2022

EU and European Disability Forum laud efforts of Sightsavers in India

This targeted capacity-building and advocacy project in 15 districts and 5 states of India has facilitated the certification of disability for 11,152 people, provided disability pensions to 8,144 people and supported the issuing of voter IDs to 8,450 people with disabilities


ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
Biotech | March 27, 2022

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training

The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment


Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
News | March 25, 2022

CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma

Recommendation is based on pivotal data from the phase III POLARIX study


MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures
Startup | March 24, 2022

MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures

MedisimVR is a VR based medical education platform for doctors, nurses & allied health professionals. It aims to make comprehensive Virtual Reality medical simulation more accessible and affordable


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India
News | March 24, 2022

Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India

This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system